Research Progress and Prospects of Flavonoids in the Treatment of Diseases by Regulating Autophagy: A Narrative Review
Molecules · 11.06.2026 · 31 (12) · 2055
DOI: 10.3390/molecules31122055 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 11.06.2026. Verfasst von Shuang Xue und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin 150040, China. Hauptthemen laut MEDLINE: Flavonoids, Autophagy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, "Basic Research Support Program for Outstanding Young Teachers" of Heilongjiang Provincial Undergraduate Universities, 2025 Heilongjiang Provincial Natural Science Foundation Joint Fund Cultivation Project.
Abstract (Originalsprache)
Autophagy is an essential mechanism through which cells break down and reuse intracellular proteins and organelles to preserve cellular homeostasis. Under physiological conditions, autophagy primarily exerts a cytoprotective effect; however, aberrant activation or deficiency of autophagy pathways can disturb cellular balance and even trigger apoptosis, thereby contributing to the occurrence and progression of multiple diseases. Flavonoids are natural bioactive components widely distributed in plants, characterized by distinct benefits of synergistic regulation via multiple targets and pathways. This review summarizes the primary mechanisms of flavonoids, focusing on their potential underlying mechanisms against various diseases—including atherosclerosis, cardiovascular diseases, liver diseases, lung diseases, Parkinson’s disease, leukemia, and malignant tumors—via regulating autophagy (including selective autophagy), and sorts out the latest advances in related experimental research over the past five years. In conclusion, flavonoids can effectively ameliorate the pathological processes of multiple diseases by modulating autophagy pathways with favorable biosafety. Nevertheless, low bioavailability remains the core bottleneck restricting their clinical translation. Further optimization of pharmaceutical formulations is warranted to enhance their uptake efficacy in vivo, and rigorous clinical trials are needed to assess their prolonged effectiveness and potential drug interactions, so as to offer new feasible approaches and research directions for the prophylaxis and therapy of various diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Förderung
- National Natural Science Foundation of China
- "Basic Research Support Program for Outstanding Young Teachers" of Heilongjiang Provincial Undergraduate Universities
- 2025 Heilongjiang Provincial Natural Science Foundation Joint Fund Cultivation Project
- “Basic Research Support Program for Outstanding Young Teachers” of Heilongjiang Provincial Undergraduate Universities
Zitieren
APA
Xue, S., Wang, Q., Guo, X., Chen, X., Zhou, Y., Yang, J., Zhang, Y., & Niu, W. (2026). Research Progress and Prospects of Flavonoids in the Treatment of Diseases by Regulating Autophagy: A Narrative Review. Molecules, 31(12), 2055. https://doi.org/10.3390/molecules31122055
Vancouver
Xue S, Wang Q, Guo X, Chen X, Zhou Y, Yang J, et al. Research Progress and Prospects of Flavonoids in the Treatment of Diseases by Regulating Autophagy: A Narrative Review. Molecules. 2026;31(12):2055. doi:10.3390/molecules31122055
BibTeX
@article{Xue2026,
author = {Xue, Shuang and Wang, Qiao and Guo, Xuan and Chen, Xingtong and Zhou, Yunyue and Yang, Jinbiao and Zhang, Yukun and Niu, Wenying},
title = {Research Progress and Prospects of Flavonoids in the Treatment of Diseases by Regulating Autophagy: A Narrative Review},
journal = {Molecules},
year = {2026},
volume = {31},
number = {12},
pages = {2055},
doi = {10.3390/molecules31122055}
}
EUVIMED